Gieseck Richard L, Vallier Ludovic, Hannan Nicholas R F
Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren Laboratory for Regenerative Medicine, Department of Surgery, University of Cambridge, Robinson Way, Cambridge, CB2 0SZ, UK.
Methods Mol Biol. 2015;1250:123-42. doi: 10.1007/978-1-4939-2074-7_9.
Hepatocytes produced from the differentiation of human pluripotent stem cells can be used to study human development and liver disease, to investigate the toxicological response of novel drug candidates, and as an alternative source of primary cells for transplantation therapies. Here, we describe a method to produce hepatocytes by differentiating human pluripotent stem cells into definitive endoderm, patterning definitive endoderm into anterior definitive endoderm, specifying anterior definitive endoderm into hepatic endoderm, and differentiating hepatic endoderm into immature hepatocytes. These cells are further matured in either two-dimensional or three-dimensional culture conditions to produce cells capable of metabolizing xenobiotics and generating liver-specific proteins, such as albumin and alpha 1 antitrypsin.
由人类多能干细胞分化产生的肝细胞可用于研究人类发育和肝脏疾病,调查新型候选药物的毒理学反应,并作为移植治疗中原代细胞的替代来源。在此,我们描述了一种通过将人类多能干细胞分化为定形内胚层、将定形内胚层分化为前定形内胚层、将前定形内胚层指定为肝内胚层以及将肝内胚层分化为未成熟肝细胞来产生肝细胞的方法。这些细胞在二维或三维培养条件下进一步成熟,以产生能够代谢外源性物质并生成肝脏特异性蛋白质(如白蛋白和α1抗胰蛋白酶)的细胞。